Suppr超能文献

化疗会改变血栓调节蛋白和因子VIIIc的表达,导致获得性活化蛋白C抵抗,并增强癌症相关性血栓形成中的凝血酶生成。

Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis.

作者信息

Ward M P, Ibrahim E M, O'Toole S A, Marchocki Z, O'Leary J J, Saadeh F Abu, Norris L A

机构信息

Trinity St. James's Cancer Institute, Dublin, Ireland; Dept Of Histopathology, Trinity College Dublin, Ireland.

Department of Obstetrics and Gynaecology, Trinity College Dublin, Dublin, Ireland; Division of Gynae-oncology, Trinity St. James's Cancer Institute, Dublin, Ireland; Trinity St. James's Cancer Institute, Dublin, Ireland.

出版信息

Thromb Res. 2025 Feb;246:109251. doi: 10.1016/j.thromres.2024.109251. Epub 2024 Dec 30.

Abstract

BACKGROUND

Tumour type, treatment and patient related factors contribute to cancer associated venous thromboembolism (VTE), however, the role of each factor and the mechanisms involved are not understood.

AIM

To assess the role of the tumour, and of chemotherapy, in mediating the procoagulant response associated with VTE in gynaecological cancer patients.

METHODS

Gynaecological cancer patients who developed VTE during follow-up (n = 59) (VTE+) were matched with treatment naïve(treatment (-)(VTE-)(n = 120) and chemotherapy treated patients(treatment (+)(VTE-) (n = 57)). Thrombin generation, Factor V(FV), VIIIc(FVIIIc), Tissue Factor Pathway Inhibitor(TFPI), soluble Thrombomodulin(sTM), Protein S(PS), C(PC) endothelial protein C receptor(EPCR) and fibrinogen were compared in each group. EPCR and TM expression was assessed in EA.hy926 cells in vitro following addition of chemotherapy agents. mRNA expression of coagulation genes was measured in tumour biopsies.

RESULTS

Thrombin generation was increased in treatment(-)VTE(+) compared with treatment(-)VTE(-) controls but not in the treatment(+)VTE(+) patients. Using the TM modified assay, thrombin generation was increased in the treatment (+)VTE(-) group compared with treatment(-)(VTE-) with a further increase in the treatment (+) VTE(+) group. Reduced levels of sTM in treatment (+) VTE(+) patients correlated with thrombin generation. TM expression was reduced in vitro by carboplatin and paclitaxel. FVIIIc was increased in both VTE groups and was predictive of VTE. F5 mRNA levels were lower in tumours from VTE(+) patients compared with controls.

CONCLUSION

Chemotherapy alters sTM and confers an acquired activated Protein C(aPC) resistance which may be implicated in cancer associated VTE in gynaecological cancer patients. FVIIIc may be a useful predictive marker for VTE in cancer patients in this setting.

摘要

背景

肿瘤类型、治疗方法及患者相关因素均与癌症相关静脉血栓栓塞症(VTE)有关,但各因素的作用及相关机制尚不清楚。

目的

评估肿瘤及化疗在介导妇科癌症患者VTE相关促凝反应中的作用。

方法

将随访期间发生VTE的妇科癌症患者(n = 59)(VTE+)与未接受治疗的患者(治疗(-)(VTE-)(n = 120))及接受化疗的患者(治疗(+)(VTE-)(n = 57))进行匹配。比较各组的凝血酶生成、因子V(FV)、VIIIc(FVIIIc)、组织因子途径抑制物(TFPI)、可溶性血栓调节蛋白(sTM)、蛋白S(PS)、蛋白C(PC)、内皮蛋白C受体(EPCR)和纤维蛋白原。在体外添加化疗药物后,评估EA.hy926细胞中EPCR和TM的表达。在肿瘤活检组织中检测凝血基因的mRNA表达。

结果

与治疗(-)VTE(-)对照组相比,治疗(-)VTE(+)组的凝血酶生成增加,但治疗(+)VTE(+)患者中未增加。使用TM改良检测法,治疗(+)VTE(-)组的凝血酶生成比治疗(-)(VTE-)组增加,治疗(+)VTE(+)组进一步增加。治疗(+)VTE(+)患者中sTM水平降低与凝血酶生成相关。在体外,卡铂和紫杉醇可降低TM表达。两个VTE组的FVIIIc均升高,且可预测VTE。与对照组相比,VTE(+)患者肿瘤中的F5 mRNA水平较低。

结论

化疗可改变sTM并导致获得性活化蛋白C(aPC)抵抗,这可能与妇科癌症患者的癌症相关VTE有关。在这种情况下,FVIIIc可能是癌症患者VTE的有用预测标志物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验